Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02829372 |
| Title | Phase 1 Study of Single Agent GBR 1302 in Subjects With HER2 Positive Cancers (GBR 1302-101) |
| Acronym | GBR 1302-101 |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Glenmark Pharmaceuticals S.A. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | DEU |